Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2025
  • October
  • Page 121
ono’s-bms-partnered-ep4-antagonist-improves-progression-free-survival-in-phase-2-gastric-cancer-test
Posted inBiotechnology

Ono’s BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test

October 9, 2025
Ono Pharmaceutical’s EP4 antagonist hit the primary progression-free survival endpoint in a phase 2 trial in patients with gastric cancer.…
Read More
thermo-fisher-rolls-out-biopsy-test-to-better-assess-lung-transplant-rejection-risk
Posted inMedical Technology

Thermo Fisher rolls out biopsy test to better assess lung transplant rejection risk

October 9, 2025
Thermo Fisher Scientific has launched a new diagnostic test to help physicians better detect and manage lung transplant rejection. Dubbed…
Read More
aviadobio-secures-option-to-rare-eye-disease-gene-therapy-that-could-bring-chinese-biotech-$413m
Posted inBiotechnology

AviadoBio secures option to rare eye disease gene therapy that could bring Chinese biotech $413M

October 9, 2025
England's AviadoBio is looking to China as a potential source of additional gene therapies, securing an option to a $413…
Read More
novo-inks-akero-buyout-worth-up-to-$5.2b-to-bag-late-phase-mash-prospect
Posted inBiotechnology

Novo inks Akero buyout worth up to $5.2B to bag late-phase MASH prospect

October 9, 2025
Novo Nordisk has struck a deal to buy Akero Therapeutics for up to $5.2 billion, teeing up a showdown with Roche…
Read More
cdmo-catalent-strengthens-adc-pipeline-with-$10m-pact-for-lisata-tumor-drug
Posted inBiotechnology

CDMO Catalent strengthens ADC pipeline with $10M pact for Lisata tumor drug

October 9, 2025
Catalent has continued its foray into the antibody-drug conjugate space, this time penning a $10 million biobucks pact to evaluate…
Read More
us-government-pumps-money-toward-in-vivo-cell-therapy-programs
Posted inBiotechnology

US government pumps money toward in vivo cell therapy programs

October 8, 2025
After axing a wide swath of federal research projects and grants, a recent slew of awards offers a glimpse into…
Read More
neuroinflammation-a-key-underlying-factor-in-alzheimer’s-disease-risk
Posted inBiotechnology

Neuroinflammation a Key Underlying Factor in Alzheimer’s Disease Risk

October 8, 2025
New findings discussed at the latest Alzheimer’s Association International Conference (AAIC) highlight the risk factors associated with Alzheimer’s disease. Amongst…
Read More
bd,-opentrons-labs-enter-multi-year-collaboration-to-join-cell-analysis,-automation-tech
Posted inMedical Technology

BD, Opentrons Labs enter multi-year collaboration to join cell analysis, automation tech

October 8, 2025
Under a multi-year deal, medtech company BD and lab automation specialist Opentrons Labworks are joining forces to leverage their respective…
Read More
oxford-biodynamics-unveils-new-target-use-for-episwitch-blood-test
Posted inMedical Technology

Oxford BioDynamics unveils new target use for EpiSwitch blood test

October 8, 2025
Oxford BioDynamics, a U.K.-based maker of precision diagnostics, touted progress toward a first-of-its-kind blood test for chronic fatigue syndrome (CFS)—also…
Read More
arthrosi-raises-$153m,-fueling-dash-toward-phase-3-gout-data-in-2026
Posted inBiotechnology

Arthrosi raises $153M, fueling dash toward phase 3 gout data in 2026

October 8, 2025
Arthrosi Therapeutics has raised $153 million to bankroll its bid to clout gout. The series E financing gives the biotech the…
Read More

Posts pagination

Previous page 1 … 119 120 121 122 123 124 Next page

Privacy Policy    Terms

Scroll to Top